एपीए उद्धरण

Avgerinos, K. I., Ferrucci, L., & Kapogiannis, D. (2021). Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer’s disease. Ageing Res Rev.

शिकागो स्टाइल उद्धरण

Avgerinos, Konstantinos I., Luigi Ferrucci, और Dimitrios Kapogiannis. "Effects of Monoclonal Antibodies against Amyloid-β On Clinical and Biomarker Outcomes and Adverse Event Risks: A Systematic Review and Meta-analysis of Phase III RCTs in Alzheimer’s Disease." Ageing Res Rev 2021.

एमएलए उद्धरण

Avgerinos, Konstantinos I., Luigi Ferrucci, और Dimitrios Kapogiannis. "Effects of Monoclonal Antibodies against Amyloid-β On Clinical and Biomarker Outcomes and Adverse Event Risks: A Systematic Review and Meta-analysis of Phase III RCTs in Alzheimer’s Disease." Ageing Res Rev 2021.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.